CoChat

Inflammation in multiple sclerosis: the good, the bad, and the complex

Martino, Gianvito, Adorini, Luciano, Rieckmann, Peter, Hillert, Jan, Kallmann, Boris, Comi, Giancarlo, Filippi, Massimo · 2002 · The Lancet Neurology

The DOI matches its Crossref record; 129 of the 131 references it cites were found in a registry or an index.

Abstract

Inflammation has always been thought of as detrimental in the pathophysiology of multiple sclerosis (MS). However, emerging genetic data, magnetic-resonance-imaging studies, and immunopathological evidence challenge this simplistic view. The evidence leads to the conclusion that inflammation is tightly regulated, and that its net effect may be beneficial in MS, thus explaining some of the results from recent trials of anti-inflammatory agents. We argue that the use of anti-inflammatory drugs to treat MS may not be appropriate in all cases. Precise identification of the inflammatory pathways to be targeted in the different phases of the disease and the timing of such interventions are therefore crucial.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(02)00223-5

Cites

129 of 129 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 129 references

Research works printed but not linked: 3

  1. Masterman, 2000, HLA-DR15 is associated with lower age at onset in multiple sclerosis, Ann Neurol, 48, 211, 10.1002/1531-8249(200008)48:2<211::aid-ana11>3.0.co;2-r · doi:10.1002/1531-8249(200008)48:2<211::aid-ana11>3.0.co;2-r
  2. T Masterman A Ligers Z Zhang et al CTLA4 polymorphisms influence disease course in multiple sclerosis. J Neuroimmunol (in press).
  3. Coles, 1999, Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis, Ann Neurol, 46, 296, 10.1002/1531-8249(199909)46:3<296::aid-ana4>3.0.co;2-# · doi:10.1002/1531-8249(199909)46:3<296::aid-ana4>3.0.co;2-#

Cited by

See all 154

Metadata

Authors
Martino, G., Adorini, L., Rieckmann, P., Hillert, J., Kallmann, B., Comi, G., & Filippi, M.
Affiliations
  • IRCCS Ospedale San Raffaele (IT)
  • University of Würzburg (DE)
Corresponding author
Martino, Gianvito
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2002-12
Volume
1
Issue
8
Pages
499-509
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2087776102
Cited by
142
References
131
Citations by year
2025: 2 · 2024: 6 · 2023: 4 · 2022: 1 · 2021: 3 · 2019: 3 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 1 · 2014: 7 · 2013: 9 · 2012: 8
FWCI
2.09
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
Funders
Ministero della Salute
Topics
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
multiple sclerosis, inflammation, anti-inflammatory therapy, neuroinflammation, disease-modifying therapy, inflammatory signaling, immunopathology, disease phases, intervention timing
MeSH terms
Brain, Humans, Immunotherapy, Inflammation, Magnetic Resonance Imaging, Multiple Sclerosis, Magnetic Resonance Spectroscopy, Radiographic Image Enhancement

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inflammation in multiple sclerosis: the good, the bad, and the complex. https://app.cochat.ai/papers/10.1016/s1474-4422(02)00223-5
The paper
Martino, G., Adorini, L., Rieckmann, P., Hillert, J., Kallmann, B., Comi, G., & Filippi, M. (2002). Inflammation in multiple sclerosis: the good, the bad, and the complex. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(02)00223-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.